BioMarin Pharmaceutical, Inc. (BMRN)
65.04
-1.66
(-2.50%)
USD |
NASDAQ |
Aug 24, 16:00
65.04
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Shareholders Equity (Quarterly) : 6.322B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.322B |
| March 31, 2026 | 6.212B |
| December 31, 2025 | 6.087B |
| September 30, 2025 | 6.057B |
| June 30, 2025 | 6.027B |
| March 31, 2025 | 5.793B |
| December 31, 2024 | 5.658B |
| September 30, 2024 | 5.413B |
| June 30, 2024 | 5.286B |
| March 31, 2024 | 5.074B |
| December 31, 2023 | 4.952B |
| September 30, 2023 | 4.897B |
| June 30, 2023 | 4.783B |
| March 31, 2023 | 4.659B |
| December 31, 2022 | 4.603B |
| September 30, 2022 | 4.569B |
| June 30, 2022 | 4.505B |
| March 31, 2022 | 4.391B |
| December 31, 2021 | 4.271B |
| September 30, 2021 | 4.266B |
| June 30, 2021 | 4.242B |
| March 31, 2021 | 4.162B |
| December 31, 2020 | 4.106B |
| September 30, 2020 | 4.054B |
| June 30, 2020 | 3.237B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.240B |
| December 31, 2019 | 3.122B |
| September 30, 2019 | 3.074B |
| June 30, 2019 | 2.961B |
| March 31, 2019 | 2.937B |
| December 31, 2018 | 2.968B |
| September 30, 2018 | 2.915B |
| June 30, 2018 | 2.885B |
| March 31, 2018 | 2.807B |
| December 31, 2017 | 2.809B |
| September 30, 2017 | 2.814B |
| June 30, 2017 | 2.796B |
| March 31, 2017 | 2.769B |
| December 31, 2016 | 2.766B |
| September 30, 2016 | 2.646B |
| June 30, 2016 | 1.918B |
| March 31, 2016 | 2.290B |
| December 31, 2015 | 2.401B |
| September 30, 2015 | 2.293B |
| June 30, 2015 | 2.357B |
| March 31, 2015 | 2.425B |
| December 31, 2014 | 1.528B |
| September 30, 2014 | 1.508B |
| June 30, 2014 | 1.462B |
| March 31, 2014 | 1.460B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Incyte Corp. | 6.344B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Vertex Pharmaceuticals, Inc. | 20.25B |
| Ionis Pharmaceuticals, Inc. | 439.74M |
| Regeneron Pharmaceuticals, Inc. | 31.71B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.72B |
| Total Liabilities (Quarterly) | 5.402B |
| Debt to Equity Ratio | 0.6672 |
| Current Ratio | 2.387 |
| Net Debt Paydown Yield | -6.52% |